Jemincare Group Announces NMPA Approval of Generic Clenil for Asthma Treatment
CompanyDrug

Jemincare Group Announces NMPA Approval of Generic Clenil for Asthma Treatment

Nona Biosciences and Atossa Therapeutics Forge Partnership to Advance Breast Cancer Therapies
CompanyDeals

Nona Biosciences and Atossa Therapeutics Forge Partnership to Advance Breast Cancer Therapies

Bayer's Vitrakvi Fully Approved by FDA for NTRK Fusion Solid Tumors
CompanyDrug

Bayer’s Vitrakvi Fully Approved by FDA for NTRK Fusion Solid Tumors

Luye Pharma Launches Rotigotine Luye in UK for Parkinson's and Restless Leg Syndrome
CompanyDrug

Luye Pharma Launches Rotigotine Luye in UK for Parkinson’s and Restless Leg Syndrome

Astellas Pharma Partners with Shanghai Pharma on Zolbetuximab Commercialization
CompanyDeals

Astellas Pharma Partners with Shanghai Pharma on Zolbetuximab Commercialization

CK Life Sciences Reports Promising Preclinical Results for TROP2-Targeted Cancer Vaccine
CompanyDrug

CK Life Sciences Reports Promising Preclinical Results for TROP2-Targeted Cancer Vaccine

Kangtai Biological's Pentavalent Rotavirus Vaccine Enters Phase III Trials
CompanyDrug

Kangtai Biological’s Pentavalent Rotavirus Vaccine Enters Phase III Trials

Zelgen Biopharma's ZG005 Approved for Gastrointestinal Tumor Trials in China
CompanyDrug

Zelgen Biopharma’s ZG005 Approved for Gastrointestinal Tumor Trials in China

HemaCell's XJ-MK-002 Gains FDA Orphan Drug Designation for Giant Platelet Syndrome
CompanyDrug

HemaCell’s XJ-MK-002 Gains FDA Orphan Drug Designation for Giant Platelet Syndrome

IVIEW Therapeutics' IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis
CompanyDrug

IVIEW Therapeutics’ IVIEW-1201 Gains FDA Orphan Drug Designation for Fungal Keratitis

Hansoh Pharma's Ibrexafungerp Approved for Vulvovaginal Candidiasis in China
CompanyDrug

Hansoh Pharma’s Ibrexafungerp Approved for Vulvovaginal Candidiasis in China

Hengrui Pharmaceuticals' Ivarmacitinib Approved for Atopic Dermatitis
CompanyDrug

Hengrui Pharmaceuticals’ Ivarmacitinib Approved for Atopic Dermatitis